Vitamin a

Reading File
Finding Sources
Searching the Web

vitamin A functions deficiency toxicity overview

Searching PubMed

"vitamin A" deficiency OR supplementation

Reading File
Reading File
Reading File
Reading File
Reading File
I now have thorough information from multiple authoritative textbooks. Let me compile the comprehensive answer.

Vitamin A

Overview

Vitamin A is a fat-soluble vitamin - a collective term for a family of structurally related compounds called retinoids. It exists in several biologically active forms and is obtained from both animal and plant sources.

Chemistry and Forms

FormSource / Role
RetinolPrincipal circulating form; transport and storage (as retinyl ester)
Retinal (retinaldehyde)Active in vision (component of rhodopsin)
Retinoic acidActive in gene regulation and differentiation
Retinyl estersStorage form (especially retinyl palmitate in liver)
β-caroteneProvitamin A (plant source); cleaved to yield retinol
The 20-carbon structure contains a β-ionone ring and an isoprenoid side chain. About 1,000 carotenoid compounds exist, but only ~50 have provitamin A activity - the main ones are β-carotene, α-carotene, and β-cryptoxanthin.
Conversion: 10,000 IU = 3,000 mcg retinol activity equivalents (RAE)

Dietary Sources

  • Preformed vitamin A (retinol): Liver, fish oils, egg yolk, dairy (milk, butter, cream)
  • Provitamin A (carotenoids): Carrots, pumpkin, squash, sweet potato, spinach, apricots, grapefruit, green leafy vegetables
  • In the US diet, ~75% comes from preformed retinol and ~25% from carotenoids

Metabolism

  1. Absorption: Requires bile salts, pancreatic lipase, and dietary fat. β-carotene is converted to retinol in the intestinal wall.
  2. Transport: Retinol is packaged into chylomicrons and transported via lymphatics to the liver.
  3. Storage: >90% of body stores are in the liver (predominantly in perisinusoidal stellate/Ito cells as retinyl esters). Sufficient reserves for at least 6 months.
  4. Release: Bound to retinol-binding protein (RBP), which is synthesized in the liver. Peripheral tissues take it up via RBP surface receptors; RBP is then recycled.
  5. Activation: Retinol → retinal (reversible) → retinoic acid (irreversible)

Functions

1. Vision

  • Retinal combines with opsin to form visual pigments: rhodopsin (in rods, for dim light) and iodopsins (3 types in cones, for color vision)
  • Deficiency reduces synthesis of all four pigments

2. Epithelial Differentiation

  • Maintains mucus-secreting columnar epithelium throughout the body
  • Without vitamin A, epithelium undergoes squamous metaplasia → keratinization
  • Acts through retinoic acid receptors (RARs) forming heterodimers with retinoid X receptors (RXRs), which bind retinoic acid response elements (RAREs) in gene regulatory regions

3. Immune Function

  • Supplementation reduces diarrhea morbidity by ~15% and mortality by ~30%
  • Promotes regeneration of damaged epithelia; required for optimal immune function
  • In deficient populations, supplementation reduces overall mortality by 20-30%

4. Cell Growth and Differentiation

  • RAR/RXR heterodimers regulate expression of growth factor receptors, tumor suppressor genes, and secreted proteins
  • Controls cell-cycle progression

5. Metabolic Effects

  • Retinoids inhibit adipogenesis and stimulate lipid breakdown
  • RXR forms heterodimers with PPARs and vitamin D receptors

6. Reproduction and Fetal Development

  • Essential for spermatogenesis, fetal organogenesis, and normal embryonic development

Deficiency

Causes: Poor dietary intake (most common worldwide), fat malabsorption (celiac disease, Crohn disease, colitis), bariatric surgery, continuous use of mineral oil laxatives.

Clinical Manifestations

Ocular (xerophthalmia) - progression:
  1. Night blindness - earliest sign; impaired rhodopsin synthesis
  2. Xerosis conjunctivae - dryness of conjunctiva (lacrimal/mucus epithelium replaced by keratinized epithelium)
  3. Bitot spots - keratin debris plaques on conjunctiva
  4. Keratomalacia - softening and destruction of the cornea → irreversible blindness
Other manifestations:
  • Squamous metaplasia of respiratory epithelium → loss of mucociliary clearance → recurrent pulmonary infections
  • Desquamation of keratin debris in urinary tract → renal/bladder stones
  • Follicular/papular dermatosis (hyperkeratosis of skin with plugging of adnexal ducts)
  • Impaired immune function and increased susceptibility to infections

Toxicity (Hypervitaminosis A)

Vitamin A is a dose- and duration-dependent hepatotoxin. Only preformed retinol causes toxicity - β-carotene does not (excess causes carotenodermia, not toxicity).

Acute Toxicity

Caused by single massive dose (e.g., polar bear liver - historically well known):
  • Headache, dizziness, vomiting, stupor, blurred vision
  • Can mimic a brain tumor (pseudotumor cerebri / raised ICP)

Chronic Toxicity

Typical dose in reported liver disease cases: ~100,000 IU/day over ~7.2 years (mean cumulative dose 229 million IU). Liver injury reported at 10,000-45,000 IU/day; cirrhosis at 25,000 IU/day for ≥6 years:
  • Weight loss, anorexia, nausea, vomiting
  • Bone and joint pain; increased fracture risk (osteoclast stimulation by retinoic acid)
  • Hepatotoxicity - from stellate cell hyperplasia/hypertrophy → sinusoidal obstruction → portal hypertension → cirrhosis
  • Skin and CNS involvement
Liver biopsy findings:
  • Greenish autofluorescence under UV light (characteristic)
  • Enlarged stellate cells in space of Disse → "Swiss cheese" / honeycomb appearance
  • Perisinusoidal fibrosis, microvesicular steatosis
  • Cirrhosis (59%), chronic hepatitis (34%), perisinusoidal fibrosis (14%), peliosis (3%)
Important note: Water-miscible preparations are up to 10x more toxic than oil-based forms due to higher peak plasma and hepatic levels.
Teratogenicity: High-dose vitamin A is category X in pregnancy - causes craniofacial, cardiac, CNS, and thymic malformations.

Reference Ranges and Dosing

PopulationValue
Normal serum retinol1.05-2.09 µmol/L (30-60 µg/dL)
US RDA (adults)700-900 mcg RAE/day
Tolerable upper intake level3,000 mcg RAE/day (10,000 IU)
Pediatric dosing for measles (Harriet Lane):
  • <6 months: 50,000 IU/day × 2 days
  • 6 months to <1 year: 100,000 IU/day × 2 days
  • 1-5 years: 200,000 IU/day × 2 days

Clinical Uses

  • Measles - reduces complications and mortality in deficient/at-risk children
  • Synthetic retinoids (tretinoin, isotretinoin) - acne, psoriasis, acute promyelocytic leukemia (APL)
  • Malabsorption syndromes - prophylaxis (10,000-50,000 IU/day water-miscible form)
  • Cystic fibrosis - supplementation to prevent deficiency

Sources: Robbins & Kumar Basic Pathology, p. 292-293 | Sleisenger & Fordtran's GI & Liver Disease | Tietz Textbook of Laboratory Medicine, 7th Ed. | Harriet Lane Handbook, 23rd Ed.
This is a shared conversation. Sign in to Orris to start your own chat.